scholarly journals 128O Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes

2018 ◽  
Vol 13 (4) ◽  
pp. S72-S73 ◽  
Author(s):  
D. Planchard ◽  
M. Boyer ◽  
J-S. Lee ◽  
A. Dechaphunkul ◽  
P. Cheema ◽  
...  
Keyword(s):  
Advanced Nsclc ◽  
Standard Of Care ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Egfr Tki

scholarly journals Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes

2018 ◽  
Vol 29 ◽  
pp. ix150 ◽  
Author(s):  
D. Planchard ◽  
M. Boyer ◽  
J.-S. Lee ◽  
A. Dechaphunkul ◽  
P. Cheema ◽  
...  
Keyword(s):  
Advanced Nsclc ◽  
Standard Of Care ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Egfr Tki

scholarly journals Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC: FLAURA

2017 ◽  
Vol 28 ◽  
pp. v635 ◽  
Author(s):  
S. Ramalingam ◽  
T. Reungwetwattana ◽  
B. Chewaskulyong ◽  
A. Dechaphunkul ◽  
K.H. Lee ◽  
...  
Keyword(s):  
Advanced Nsclc ◽  
Standard Of Care ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Egfr Tki

scholarly journals Left Atrial Appendage Closure Devices For Stroke Prevention

2014 ◽  
Vol 3 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Sunil Kapur ◽  
Moussa Mansour
Keyword(s):  
Left Atrial ◽  
Left Atrial Appendage ◽  
Standard Of Care ◽  
Atrial Appendage ◽  
First Line ◽  
Current Standard ◽  
First Line Therapy ◽  
Line Therapy ◽  
Patients At Risk ◽  
Review Current

Cardioembolic stroke is a major cause of morbidity and mortality in patients with atrial fibrillation (AF). The left atrial appendage (LAA) is the prominent source of clot formation. While systemic anticoagulation is the current standard of care, anticoagulants carry many contraindications and possible complications. Techniques for elimination of the LAA are in various stages of development and early clinical use. In the coming years, accumulating data will help guide the management of AF patients at risk of bleeding as well as potentially become first-line therapy to reduce the risk of thromboembolic stroke. The purpose of this article is to review current endovascular and epicardial catheter-based LAA occlusion devices and the clinical data supporting their use.

scholarly journals Combination of EGFR-TKIs and Chemotherapy as First-Line Therapy for Advanced NSCLC: A Meta-Analysis

PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e79000 ◽  
Author(s):  
Pu-Yun OuYang ◽  
Zhen Su ◽  
Yan-Ping Mao ◽  
Wuguo Deng ◽  
Fang-Yun Xie
Keyword(s):  
Advanced Nsclc ◽  
Meta Analysis ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Egfr Tkis

Standard of Care in First-Line Therapy of DLBCL

2018 ◽  
pp. 145-155
Author(s):  
Greg Nowakowski ◽  
Fabian Frontzek ◽  
Norbert Schmitz
Keyword(s):  
Standard Of Care ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document